Biography of Katharine Knobil
Last update: March 15, 2024Career
Katharine was Chief Medical Officer at Agilent Technologies, and Director at Arena Pharmaceuticals. Katharine Knobil joined Marker Therapeutics in 2024.
Katharine Knobil is currently- Chief Medical Officer at Agilent Technologies - View - Agilent Technologies org chart
- Director at Marker Therapeutics - View - Marker Therapeutics org chart
- Director at Nimbus Therapeutics - View - Nimbus Therapeutics org chart
- Director at Pliant Therapeutics - View - Pliant Therapeutics org chart
Create your alert
to follow the career of Katharine Knobil.
Education
Katharine Knobil has a Doctor of Medicine from The University of Texas Southwestern Medical School and a Residence in Internal Medicine from University of Michigan Medical School.
More about Katharine Knobil
Selected links
Do you need to know more about Katharine Knobil? More results.
Participate
Social media
- Katharine Knobil on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Katharine Knobil
The colleagues of Katharine Knobil
Company Colleagues
- At Agilent Technologies, Katharine Knobil has 41 colleagues including Padraig McDonnell (CEO), Mala Anand (Director)…
- At Marker Therapeutics, Katharine Knobil has 10 colleagues including Steve Elms (Director), Glynn Wilson (Director)…
- At Nimbus Therapeutics, Katharine Knobil has 20 colleagues including Jeb Keiper (CEO & Director), Bruce Booth (Chairman of the Board)…
- At Pliant Therapeutics, Katharine Knobil has 31 colleagues including Bernard Coulie (CEO & Director), Smital Shah (Director)…
Industry Colleagues
- In the Biotechnology industry, Katharine Knobil has 30,322 colleagues in 2,286 companies located in 40 countries. 14,308 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Katharine Knobil.
Get in Touch
and ask for Katharine Knobil.
